Clinical Trials
Epilepsy Patients To Receive Brain Laser Therapy From NHS
The NHS has made public its intentions to provide an avant-garde laser therapy for patients with epilepsy who have not previously responded well to existing treatments, known as laser interstitial thermal therapy (LITT).
Up to 150 NHS patients might possibly...
Clinical Trials
Over Five Years, Clinical Studies In The UK Have Plunged
An industry analysis on October 20th revealed that the number of clinical trials launched annually in Britain decreased by 41% between 2017 and 2021, creating a "clear and significant threat" to its reputation as a destination for clinical research.
The...
Clinical Trials
Pistoia Alliance To Explore Clinical Trial Ecology Influence
The Clinical Trials Environmental Impact Community of Interest (CoI) has been launched by The Pistoia Alliance, a global, non-profit alliance that promotes increased collaboration in life sciences R&D. Its goal is to calculate and compare the carbon footprints of...
Clinical Trials
GSKs Latecomer Jemperli Beats Keytruda In Lung Cancer Trial
The standard therapy for newly diagnosed metastatic non-small cell lung cancer is Keytruda by Merck. That is the standard that PD-1 latecomer GSK's Jemperli must meet, and the medication has succeeded in doing so.
In a phase 2 trial, individuals...
Clinical Trials
Testing Expert: Omicron Virus Likely To Secure Against Flu
Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns in the fall. Interestingly, according to a top testing specialist, if you recently had a case of COVID, you...
Clinical Trials
US Clinical Trial To Test Antiviral For Monkeypox Starts
In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat, better known as TPOXX. The study's researchers hope to include more than 500 participants from...
Clinical Trials
Discoveries About Lumakra Lung Cancer Bolster The KRAS Fight
Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker is giving an early peek at the precise data that might set the benchmark for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
